The new law will take effect once regulations are established, in which regulators have until March 1, 2022.
The DEA’s website did not provide a timeline as to when it anticipates finalizing the applicants’ grow authorizations or when it plans to take actions on the dozens of remaining applications that are still pending before the agency.
“Overwhelming majorities of patients and their providers acknowledge that cannabis is a legitimate medicine. Politicians should not be standing in their way by opposing efforts to permit health professionals from recommending cannabis to their patients in instances where they believe it is therapeutically appropriate.”
A bicameral conference committee approved the policy change as part of a broader omnibus bill related to healthcare.
“This measure is an important first step for Alabamans.”
Members of the Ohio State Medical Board have approved requests to expand the list of qualifying conditions to include: arthritis, chronic migraines, and complex regional pain syndrome.
“The most vulnerable Mississippians will continue to be denied safe access to a therapy that could offer them significant relief from severely debilitating conditions.”
State regulators are expected in the coming months to award licenses to eligible applicants to begin cultivating cannabis and manufacturing oil extract products.